U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07353502) titled 'miR-342-5p/AnkG Pathway in Early AD Synaptic Dysfunction' on Sept. 17, 2025.
Brief Summary: Alzheimer's disease is the most common memory loss disease among the elderly. This disease affects the patient's memory, language, attention, and behavioral abilities. Current research has found that in the early stages of the disease, synaptic connections between brain nerve cells become abnormal, but the specific cause is still unclear. Investigators' previous research discovered that in the brains of diseased mice, certain special substances (the miR 342 5p/AnkG-mediated pathway) might be related to this abnormality, and these substances c...